Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study

Fig. 2

Lysophosphatidylcholines (LPCs) and prostate cancer risk. a Spearman’s correlation coefficient (Corr.) matrix for the LPCs Cx:y (n = 1554). Cluster (1): x ≤ 20, cluster (2): x > 20, where strength of each correlation is indicated by the colour intensity (red scale). b Odds ratio (OR) values for plasma LPCs (x ≤ 20) in the different subgroups before (top panel) and after (bottom panel) adjusting for the total sum of plasma LPCs Σ(x ≤ 20). OR > 1, red; OR < 1, blue; level of significance is indicated by the size of the black circles

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us